Moreover, mutational activation of EGFR and ligand stimulation of wild-type EGFR has been reported to result in Beclin 1 tyrosine phosphorylation, which leads to autophagy suppression, tumor growth, and tumor dedifferentiation in NSCLC xenografts (Wei et al., 2013). The gene discussed is EGFR; the disease is neoplasm.